References
- Ali H, Kalashnikova I, White MA, Sherman M, Rytting E. 2013. Preparation, characterization, and transport of dexamethasone-loaded polymeric nanoparticles across a human placental in vitro model. Int J Pharm 454:149–57
- Audus KL, Bartel RL, Hidalgo IJ, Borchardt RT. 1990. The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm Res 7:435–51
- Barker DJ, Thornburg KL. 2013. Placental programming of chronic diseases, cancer and lifespan: a review. Placenta 34:841–5
- Li H, van Ravenzwaay B, Rietjens IM, Louisse J. 2013. Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds. Arch Toxicol 87:1661–9
- Mathiesen L, Mose T, Morck TJ, Nielsen JK, Nielsen LK, Maroun LL, et al. 2010. Quality assessment of a placental perfusion protocol. Reprod Toxicol 30:138–46
- Nanovskaya TN, Nekhayeva IA, Hankins GD, Ahmed MS. 2008. Transfer of methadone across the dually perfused preterm human placental lobule. Am J Obstet Gynecol 198:126.e1–4
- Poulsen MS, Mose T, Maroun LL, Mathiesen L, Knudsen LE, Rytting E. 2015. Kinetics of silica nanoparticles in the human placenta. Nanotoxicology 9(S1):79–86
- Poulsen MS, Rytting E, Mose T, Knudsen LE. 2009. Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion. Toxicol In Vitro 23:1380–6
- Rytting E, Bryan J, Southard M, Audus KL. 2007. Low-affinity uptake of the fluorescent organic cation 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide (4-Di-1-ASP) in BeWo cells. Biochem Pharmacol 73:891–900
- Rytting E, Ahmed MS. 2013. Fetal drug therapy. In Mattison DR, ed. Clinical Pharmacology during Pregnancy. Amsterdam: Elsevier, 55--72
- Saunders M. 2009. Transplacental transport of nanomaterials. Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:671–84